At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 50 enrolled
Drug / intervention
Placebo +1 moredrug
Likely dose
N-Acetyl Cysteine 600mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double-Blind, Placebo-Controlled Study of N-Acetyl Cysteine in Trichotillomania
In Brief
A Phase 2 clinical trial evaluating Placebo and N-Acetyl Cysteine for Trichotillomania. Completed, enrolled 50 participants across 1 site.
Detailed Summary
This is a 12-week, double-blind study of N-Acetyl Cysteine in the treatment of trichotillomania
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTrichotillomania
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2006
First PostedJul 2006
Primary CompletionSep 2008
TodayJul 2026
First PostedJul 20, 2006
Enrollment StartJul 1, 2006
Primary CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 19.9 years ago
Interventions
Placebodrug
daily
N-Acetyl Cysteinedrug
600mg capsules in varying doses for 12 weeks.